How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

7,043 results for

Medication Cost Assistance Program

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Association Between Supplemental Nutrition Assistance Program Participation and Cost-Related Medication Nonadherence Among Older Adults With Diabetes. (PubMed)

Association Between Supplemental Nutrition Assistance Program Participation and Cost-Related Medication Nonadherence Among Older Adults With Diabetes. Understanding if the association of social programs with health care access and utilization, especially among older adults with costly chronic medical conditions, can help in improving strategies for self-management of disease.To examine whether participation in the Supplemental Nutrition Assistance Program (SNAP) is associated with a reduced (...) . The data analysis was performed from October 2017 to April 2018.Self-reported participation in SNAP.Cost-related medication nonadherence derived from responses to whether in the past year, older adults with diabetes delayed refilling a prescription, took less medication, and skipped medication doses because of cost. To estimate the association between participation in SNAP and cost-related medication nonadherence, we used 2-stage, regression-adjusted propensity score matching, conditional

2018 JAMA Internal Medicine

2. Cost-effectiveness of the pharmacist-assisted warfarin monitoring program at a Medical Center in Taiwan. (PubMed)

Cost-effectiveness of the pharmacist-assisted warfarin monitoring program at a Medical Center in Taiwan. To investigate the cost-effectiveness of the first patient self-paying pharmacist-assisted warfarin monitoring (PAWM) program in Taiwan.A Markov model with a 1-month cycle length and a 20-year time horizon was employed in this study. The model is composed of the following eight states: three no-event states (i.e. 'subtherapeutic,' 'within therapeutic' and 'supratherapeutic' states), two (...) -effectiveness ratios (ICERs).The PAWM program resulted in an average of 0.13 QALYs gained and a cost increment of NT$53 850 (US$1683) per patient. As the ICER (NT$410 749 [US$12 836]) was less than the gross domestic product per capita (NT$631 142 [US$19 723]), the PAWM was considered to be very cost-effective. The sensitivity analyses suggested that our result was robust and that the PAWM program had an 86% probability of being very cost-effective.Even if the costs saved from avoiding AEs were thought

Full Text available with Trip Pro

2017 International Journal for Quality in Health Care

3. Medication Cost Assistance Program

Medication Cost Assistance Program Medication Cost Assistance Program Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Medication Cost (...) Assistance Program Medication Cost Assistance Program Aka: Medication Cost Assistance Program , Drug Coupons , Medication Discount Cards From Related Chapters II. Types Discount Cards Initial purchase of discount card offers discounts on select medications Benefit to an individual varies based on which medications are discounted Discount card programs may sell user information to third parties Drug Coupons Only temporary discounts for expensive medications Once the coupon is used, the drug price returns

2018 FP Notebook

4. The impact of patient assistance programs and the 340B Drug Pricing Program on medication cost. (PubMed)

The impact of patient assistance programs and the 340B Drug Pricing Program on medication cost. Patient assistance programs and the 340B Drug Pricing Program promise to improve the financial stability, better serve vulnerable patients, and decrease the burden of cost for uninsured patients. Our objective is to examine the financial impact that PAPs and the 340B Program have on improving medication cost.Retrospective analysis of medication dispensary data.Dispensary data for uninsured patients (...) obtaining medications at 2 community health centers were collected from February 1 to February 29, 2012. Uninsured patients were divided into 2 samples: (1) patients receiving PAP medications and (2) patients receiving 340B medications. The main outcome measured was the patient's cost savings. Cost savings were calculated based on the amount a medication would have cost had it been purchased by patients at prices found on Epocrates software (drugstore.com). A paired sample t test model using continuous

2014 American Journal Of Managed Care

5. The Medication Pass Nutritional Supplement Program in Patients Receiving Medication

The Medication Pass Nutritional Supplement Program in Patients Receiving Medication Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. Rapid responses (...) Supplement Program in Patients Receiving Medication: A Review of Clinical Effectiveness and Guidelines DATE: 25 March 2015 CONTEXT AND POLICY ISSUES Malnutrition is a problematic issue in the healthcare system, especially in the elderly population. Among the hospitalized older population in Europe, United States and South Africa, the prevalence of malnutrition is estimated to 22.8%, with 39 to 47% being at risk. 1 In long-term care in the United States, 74% of residents are estimated to be at risk

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

6. Pharmaceutical assistance programs to support smoking cessation medication access (PubMed)

Pharmaceutical assistance programs to support smoking cessation medication access Rural smokers are more likely to be uninsured and live in poverty, which may pose significant cost barriers to accessing smoking cessation medications. As part of a randomized clinical trial, we provided support to connect low-income smokers with the use of pharmaceutical assistance programs (PAPs) to improve medication access.Study participants were rural smokers enrolled in a randomized clinical trial testing (...) the application and ultimately receiving medications through the programs. Despite the availability of assistance with the PAP application process, overall medication use among those that were eligible for PAP was significantly lower than among participants with higher incomes or access to prescription insurance (60.4% vs. 51.3%; P = 0.04). Abstinence among PAP-eligible smokers was also lower at the 3-month follow-up (P = 0.01), but this difference was not present at the 6- and 12-month follow-up surveys.With

Full Text available with Trip Pro

2016 Journal of the American Pharmacists Association : JAPhA

7. Utilization of Pharmaceutical Patient and Prescription Assistance Programs via a Pharmacy Department Patient Assistance Program for Indigent Cancer Patients (PubMed)

Utilization of Pharmaceutical Patient and Prescription Assistance Programs via a Pharmacy Department Patient Assistance Program for Indigent Cancer Patients With the advances in cancer treatments, mortality rates in the United States have been consistently falling but they are accompanied by substantial increases in the cost of cancer care. Patient and prescription assistance programs (PPAPs) are offered by pharmaceutical manufacturers to provide free medications to medically indigent patients (...) . To assist the Cancer Care Center (CCC) at Nassau University Medical Center (NUMC) with drug costs for chemotherapies, the pharmacy department uses a patient assistance program (PAP) to obtain medications from the drug companies at no cost.This study evaluates the impact of the PAP at a public hospital from which indigent cancer patients obtain assistance for chemotherapy.We followed all patients requiring assistance with chemotherapy who enrolled in the PAP from January 1, 2011 through December 31, 2012

Full Text available with Trip Pro

2016 Hospital pharmacy

8. Routine psychosocial care in infertility and medically assisted reproduction ? A guide for fertility staff

Routine psychosocial care in infertility and medically assisted reproduction ? A guide for fertility staff ESHRE Psychology and Counselling Guideline Development Group March 2015 Routine psychosocial care in infertility and medically assisted reproduction – A guide for fertility staff 1 Disclaimer The European Society of Human Reproduction and Embryology (hereinafter referred to as 'ESHRE') developed the current clinical practice guideline to provide clinical recommendations to improve (...) for the provision of routine psychosocial care and to contribute to the homogenization of psychosocial care in infertility care across all European countries. 6 Scope of the guideline This document ‘Routine psychosocial care in infertility and medically assisted reproduction – A guide for fertility staff’ was written to provide guidance about two main issues. First, information is provided to fertility staff about preferences of patients regarding the psychosocial care they receive at clinics and how this care

2015 European Society of Human Reproduction and Embryology

9. Examining the Costs and Cost-effectiveness of Policies for Reducing Alcohol Consumption

and promoting public health and safety? A literature review. Contemporary Drug Problems 2012; 39(1): 7-48. McMaster Health Forum 15 Evidence >> Insight >> Action Appendix 1: Summary of key findings about costs and cost-effectiveness of policies for reducing alcohol consumption (adapted from Anderson et al.) (18) WHO-CHOICE alcohol interventions Policy options Key findings Educational information through awareness and political commitments • School-based education • Parenting programs • Social marketing (...) programs • Public information campaigns • Counter-advertising • Drinking guidelines Key findings related to costs or cost-effectiveness of policy options • One recent overview of systematic reviews found that neither school-based education nor mass-media awareness campaigns were cost-effective, given they do not notably affect consumption levels or overall health effects.(6) Additional key findings related to benefits and harms of policy options • Several reviews (one recent overview of systematic

2018 McMaster Health Forum

10. Oncology Clinicians and the Minnesota Medical Cannabis Program: A Survey on Medical Cannabis Practice Patterns, Barriers to Enrollment, and Educational Needs (PubMed)

or medical oncology nurse practitioner/physician assistant (n=125, 82%), and most practiced in a community setting (n=102, 67%). Overall, 65% of respondents supported the use of medical cannabis. Perceived cost and inadequate research were the highest barriers to MMCP patient enrollment. The lowest barriers included lack of health group support for allowing certification of patients and risk of social stigma. Of all respondents, 36% lacked confidence in discussing the risks and benefits of medical (...) Oncology Clinicians and the Minnesota Medical Cannabis Program: A Survey on Medical Cannabis Practice Patterns, Barriers to Enrollment, and Educational Needs Background: Medical cannabis has been available in the State of Minnesota since July 2015 through the Minnesota Medical Cannabis Program (MMCP). Objectives: Our study aimed to delineate oncology providers' views on medical cannabis, identify barriers to patient enrollment, and assess clinicians' interest in a clinical trial of medical

Full Text available with Trip Pro

2018 Cannabis and Cannabinoid Research

11. Adherence rates and health care costs in Crohn’s disease patients receiving certolizumab pegol with and without home health nurse assistance: results from a retrospective analysis of patient claims and home health nurse data (PubMed)

Adherence rates and health care costs in Crohn’s disease patients receiving certolizumab pegol with and without home health nurse assistance: results from a retrospective analysis of patient claims and home health nurse data Patient support programs have a positive effect on adherence to therapy. Certolizumab pegol (CZP) is a tumor necrosis factor antagonist for the treatment of Crohn's disease.To assess, using real-world claims data, whether home health nurse assistance had an effect (...) on patients' adherence to CZP and to measure its impact on health care use and costs.A retrospective analysis of medical and pharmacy claims data from the IQVIA Real-World Data Adjudicated Claims Database was conducted using data from January 1, 2007 through September 30, 2015. CZP patients with Crohn's disease were eligible to receive self-administration instructions from a nurse or nurse-administered CZP injections, or both. These services were provided by CIMplicity®, a home health nurse program

Full Text available with Trip Pro

2018 Patient preference and adherence

12. Systematic review of the cost-effectiveness of influenza immunization programs: A Canadian perspective

evaluations, these interventions could include health technologies like specific medications, hospital protocols, surgical procedures, or health promotion programs. For this thesis, the interventions in focus are influenza immunization programs in different populations. Full economic evaluations jointly analyse the costs and consequences (i.e. health outcomes) of health interventions among possible alternatives. The choice between an intervention and its comparator is instrumental to an economic (...) Systematic review of the cost-effectiveness of influenza immunization programs: A Canadian perspective The Hospital for Sick Children Technology Assessment at SickKids (TASK) FULL REPORT SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF INFLUENZA IMMUNIZATION PROGRAMS: A CANADIAN PERSPECTIVE Author: Eon Ting, BSc, MBA, MSc Supervisor and Senior Responsible Author: Wendy J. Ungar, MSc, PhD Child Health Evaluative Sciences, The Hospital for Sick Children Corresponding Author: Wendy J. Ungar, MSc

2015 SickKids Reports

13. Rationale and methods of an Evaluation of the Effectiveness of the Community Paramedicine at Home (CP@home) program for frequent users of emergency medical services in multiple Ontario regions: a study protocol for a randomized controlled trial. (PubMed)

Rationale and methods of an Evaluation of the Effectiveness of the Community Paramedicine at Home (CP@home) program for frequent users of emergency medical services in multiple Ontario regions: a study protocol for a randomized controlled trial. Frequent users of emergency medical services for issues that could be more appropriately managed through non-urgent care deplete the limited resources of the health-care system. Community paramedicine is an emerging field that extends the role (...) services in Ontario. The sample size has been calculated as 261 per group for a 25% reduction in ambulance calls. Eligible participants will be frequent callers (three or more calls in 6 months), individuals who call for at least one lift assist, or individuals referred to the program by a paramedic. Individuals will be randomly allocated to receive either the Community Paramedicine at Home (CP@home) program intervention or their usual care (control). Intervention participants will receive up to three

Full Text available with Trip Pro

2019 Trials

14. Teaching Laboratory Management Principles and Practices Through Mentorship and Graduated Responsibility: The Assistant Medical Directorship (PubMed)

Teaching Laboratory Management Principles and Practices Through Mentorship and Graduated Responsibility: The Assistant Medical Directorship With the changing landscape of medicine in general, and pathology in particular, a greater emphasis is being placed on laboratory management as a means of controlling spiraling medical costs and improving health-care efficiency. To meet this challenge, pathology residency programs have begun to incorporate formal laboratory management training (...) into their curricula, using institutional curricula and/or online laboratory management courses offered by professional organizations. At the University of Utah, and its affiliated national reference laboratory, ARUP Laboratories, Inc, interested residents are able to supplement the departmental lecture-based and online laboratory management curriculum by participating in assistant medical directorship programs in one of several pathology subspecialty disciplines. The goals of many of the assistant medical

Full Text available with Trip Pro

2016 Academic pathology

15. Robot-assisted Surgery for Partial Nephrectomy and Cardiac Surgery: A Review of the Clinical and Cost-Effectiveness ? An Update

, and cardiac surgery, the latter procedure was the least costly indication-specific program, with net program costs of $0.9 million and $2.2 million for partial nephrectomy over seven years. This report aims to update the CADTH health technology assessment report regarding the clinical effectiveness and cost-effectiveness of robot-assisted surgery for partial nephrectomy and cardiac surgery, as compared to laparoscopic and open surgical approaches. RESEARCH QUESTIONS 1. What is the updated evidence (...) interventions clearly described patient characteristics clearly described major adverse events reported main outcomes used accurate actual P values reported for main outcomes potential confounders taken into consideration learning curve taken into consideration retrospective cohort study no randomization or blinding initial capital costs of establishing a program with robotic surgery not taken into account Robot-assisted Partial Nephrectomy and Cardiac Surgery 16 Appendix 4: Main Study Findings and Authors

2012 Canadian Agency for Drugs and Technologies in Health - Rapid Review

16. Robot-assisted Surgery for Prostatectomy and Hysterectomy: A Review of the Clinical and Cost-Effectiveness ? An Update

, with net program costs of $3.5 million, while for hysterectomy the impact was $1.8 million over seven years. This report aims to update the CADTH health technology assessment report regarding the clinical effectiveness and cost-effectiveness of robot-assisted surgery for prostatectomy and hysterectomy, as compared to laparoscopic and open surgical approaches. RESEARCH QUESTIONS 1. What is the updated evidence on the clinical effectiveness of robot-assisted surgery for prostatectomy as compared to open (...) Robot-assisted Surgery for Prostatectomy and Hysterectomy: A Review of the Clinical and Cost-Effectiveness ? An Update Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources and a summary of the best evidence on the topic that CADTH could identify using all reasonable

2012 Canadian Agency for Drugs and Technologies in Health - Rapid Review

17. A review of the evidence base for modelling the costs of overweight, obesity and diet-related illness for Scotland, and critical appraisal of the cost-effectiveness evidence base for population wide interventions to reduce overweight, obesity and diet-rel

for policy makers and these are a subset of external costs. Some examples of costs are given in Figure 1, but this is not exhaustive. 12 Figure 1 Overview of costs – adapted from Leontaridi, R. (2003). Alcohol misuse: how much does it cost. London: Cabinet Office. Costs External Private Hospital visits GP visits Unemployment Absenteeism Prevention activities Costs to family and friends Private medical expenditure Quality of life Personal weight loss activities 13 For each type of cost included (...) ). Of the remaining three, one paper only considered medications costs and cost savings, one paper was a letter/commentary of conference proceedings, and one paper considered BMI 21-25 as well as overweight and obesity. This produced a final total of 14 relevant studies. 16 Figure 2 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta- Analyses) flow chart of cost of illness studies Records identified through database searching (n = 428) Screening Included Eligibility Identification Additional

2017 Health Economics Research Unit

18. Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians

that are newer and relatively expensive even when clinical practice guidelines recommend otherwise ( , ). For example, Fischer and Avorn ( ) assessed antihypertensive prescribing in a state pharmacy assistance program and estimated that physicians prescribed newer brand-name medications instead of thiazides (which were recommended by the then-current antihypertensive guidelines from the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (...) -for-performance programs have achieved modest improvements in the quality of care and could, in principle, be linked to measures associated with the use of generic drugs ( ). In accountable care organizations, providers are placed at risk for the cost of care that they provide; this could be a powerful incentive for physicians to be thoughtful about the cost of the medications they prescribe, although high-quality data evaluating this premise have yet to be published. Areas of Uncertainty and Directions

Full Text available with Trip Pro

2015 American College of Physicians

19. Supplemental Nutrition Assistance Program (SNAP) Participation and Health Care Expenditures Among Low-Income Adults. (PubMed)

Supplemental Nutrition Assistance Program (SNAP) Participation and Health Care Expenditures Among Low-Income Adults. Food insecurity is associated with high health care expenditures, but the effectiveness of food insecurity interventions on health care costs is unknown.To determine whether the Supplemental Nutrition Assistance Program (SNAP), which addresses food insecurity, can reduce health care expenditures.This is a retrospective cohort study of 4447 noninstitutionalized adults with income (...) below 200% of the federal poverty threshold who participated in the 2011 National Health Interview Survey (NHIS) and the 2012-2013 Medical Expenditure Panel Survey (MEPS).Self-reported SNAP participation in 2011.Total health care expenditures (all paid claims and out-of-pocket costs) in the 2012-2013 period. To test whether SNAP participation was associated with lower subsequent health care expenditures, we used generalized linear modeling (gamma distribution, log link, with survey design

Full Text available with Trip Pro

2017 JAMA Internal Medicine

20. Maryland Multipayor Patient-centered Medical Home Program: A 4-Year Quasiexperimental Evaluation of Quality, Utilization, Patient Satisfaction, and Provider Perceptions. (PubMed)

Maryland Multipayor Patient-centered Medical Home Program: A 4-Year Quasiexperimental Evaluation of Quality, Utilization, Patient Satisfaction, and Provider Perceptions. To evaluate impact of the Maryland Multipayor Patient-centered Medical Home Program (MMPP) on: (1) quality, utilization, and costs of care; (2) beneficiaries' experiences and satisfaction with care; and (3) perceptions of providers.4-year quasiexperimental design with a difference-in-differences analytic approach to compare (...) payments in the first year among privately insured beneficiaries, and for the entire duration among Medicaid beneficiaries. There was indication that MMPP practices shifted responsibility for certain administrative tasks from clinicians to medical assistants or care managers. The program had limited effect on measures of patient satisfaction (although response rates were low) and on provider perceptions.The MMPP demonstrated mixed results of its impact and indicated differential program effects

Full Text available with Trip Pro

2018 Medical Care

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>